Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Ligand Pharmaceuticals Incorporated, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Ligand Pharmaceuticals Incorporated June 5, 202698.1%
-
Ligand Pharmaceuticals Incorporated June 9, 202598.8%
-
Ligand Pharmaceuticals Incorporated June 14, 202498.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 12, 2026 | Ligand Pharmaceuticals Incorporated | Option exercise | +6,138 | $51.56 | $316,475 |
| Aug 12, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −7,138 | $292.81 | $2,090,078 |
| Jun 12, 2026 | Ligand Pharmaceuticals Incorporated | Option exercise | +3,000 | $51.56 | $154,680 |
| Jun 12, 2026 | Ligand Pharmaceuticals Incorporated | Option exercise | +1,000 | $51.56 | $51,560 |
| Jun 12, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −3,000 | $255.01 | $765,030 |
| Jun 12, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −3,461 | $256.08 | $886,293 |
| Jun 5, 2026 | Ligand Pharmaceuticals Incorporated | Grant or award | +836 | — | — |
| May 8, 2026 | Odyssey Therapeutics Inc. | Open-market purchase | +1,000 | $20.00 | $20,000 |
| Jun 6, 2025 | Ligand Pharmaceuticals Incorporated | Grant or award | +1,209 | — | — |
| Jun 14, 2024 | Ligand Pharmaceuticals Incorporated | Grant or award | +1,252 | — | — |
| Jun 9, 2023 | Ligand Pharmaceuticals Incorporated | Grant or award | +1,142 | — | — |
Questions about Jason Haas
What boards is Jason Haas on?
Jason Haas sits on the board of Ligand Pharmaceuticals Incorporated.
How long has Jason Haas served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.